期刊
CLINICS IN LIVER DISEASE
卷 13, 期 2, 页码 249-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2009.02.009
关键词
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Obesity; Metabolic syndrome
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of chronic liver disease in the Western world. The rise in NAFLD is thought to be associated with the prevalence of metabolic syndrome. NASH is a subtype of NAFLD that may progress to cirrhosis and end stage liver disease. Although there are no approved treatment regimens for NAFLD or NASH, a number of different interventions are being tested. Meanwhile, most experts advocate that components of metabolic syndrome should be effectively treated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据